-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Cumberland Pharmaceuticals Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2010 to 2024.
- Cumberland Pharmaceuticals Inc Amortization of Intangible Assets for the quarter ending December 31, 2024 was $1.46M, a 67.8% decline year-over-year.
- Cumberland Pharmaceuticals Inc Amortization of Intangible Assets for the twelve months ending December 31, 2024 was $4.75M, a 41.4% decline year-over-year.
- Cumberland Pharmaceuticals Inc annual Amortization of Intangible Assets for 2024 was $4.75M, a 41.4% decline from 2023.
- Cumberland Pharmaceuticals Inc annual Amortization of Intangible Assets for 2023 was $8.1M, a 59.9% increase from 2022.
- Cumberland Pharmaceuticals Inc annual Amortization of Intangible Assets for 2022 was $5.07M, a 15.9% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)